Healthcare
Live Price
Offline$25.00
+0.00% today
Window Change
-15.91%
Window
Jan 2, 2026 → Jun 24, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 119 bars · Jan 2, 2026 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Eisai Co., Ltd. (ESALF) is a Healthcare stock with a market cap of $1.32T and listed on OTC. The stock last traded around $25.00 and down 15.9% across the available one-year price window (Jan 2, 2026 → Jun 24, 2026). Baseline metrics include revenue growth of +6.4%, EPS growth of +10.8%, a dividend yield of 3.4%. What stands out right now is revenue +6.4%, EPS +10.8%, free cash flow -77.1% with operating margin 5.6% and ROIC 2.8%. The dividend matters to the case here, with a current yield around 3.4%. Valuation already assumes a fairly strong business story at P/E 30.9 and price/sales 1.6. Stock Foundry combines ESALF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
ESALF is 23.24 pts behind over the shared 1Y window.
ESALF had 22.64 pts deeper max drawdown than SPY.
ESALF beat SPY in 0 of 1 calendar years shown and trailed in 1.
ESALF
-15.91%
Normalized return
SPY
+7.33%
S&P 500
Excess Return
-23.24 pts
Relative to SPY
ESALF Max Drawdown
-31.77%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for ESALF and SPY.
| Year | ESALF | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -15.91% | +6.71% | -22.62 pts | SPY |
| 2025 | — | +11.19% | -- | -- |
Unable to load analyst forecasts.
Timed out loading forecasts for ESALF
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.